Navigation Links
Low vitamin C levels may raise heart failure patients' risk
Date:11/13/2011

Low levels of vitamin C were associated with higher levels of high sensitivity C-Reactive protein (hsCRP) and shorter intervals without major cardiac issues or death for heart failure patients, in research presented at the American Heart Association's Scientific Sessions 2011.

Compared to those with high vitamin C intake from food, heart failure patients in the study who had low vitamin C intake were 2.4 times more likely to have higher levels of hsCRP, a marker for inflammation and a risk factor for heart disease.

The study is the first to demonstrate that low vitamin C intake is associated with worse outcomes for heart failure patients.

Study participants with low vitamin C intake and hsCRP over 3 milligrams per liter (mg/L) were also nearly twice as likely to die from cardiovascular disease within one year of follow-up.

"We found that adequate intake of vitamin C was associated with longer survival in patients with heart failure," said Eun Kyeung Song, Ph.D., R.N., lead author of the study and assistant professor at the Department of Nursing, College of Medicine, in the University of Ulsan in Korea.

The average age among the 212 patients in the study was 61, and about one-third were women. Approximately 45 percent of the participants had moderate to severe heart failure.

Participants completed a four-day food diary verified by a registered dietitian and a software program calculated their vitamin C intake. Bloods tests measured hsCRP.

Researchers divided participants into one group with levels over 3 mg/L of hsCRP and another with lower levels. Patients were followed for one year to determine the length of time to their first visit to the emergency department due to cardiac problems or death.

Researchers found that 82 patients (39 percent) had inadequate vitamin C intake, according to criteria set by the Institute of Medicine. These criteria allowed the researchers to estimate the likelihood
'/>"/>

Contact: AHA News Media Office
214-706-1396
American Heart Association
Source:Eurekalert

Page: 1 2

Related biology news :

1. Obese adolescents benefit from high-dose vitamin D supplements
2. Vitamin D study suggests no mortality benefit for older women
3. Students coax yeast cells to add vitamins to bread
4. Vitamin D deficiency common in cancer patients
5. Additives meant to protect vitamin C actually cause more harm
6. A scientific go for commercial production of vitamin-D enhanced mushrooms
7. Vitamin C may be beneficial for asthmatic children
8. Pregnant women in Vancouver may not be getting enough vitamin D
9. OHSU scientists discover new role for vitamin C in the eye -- and the brain
10. Vitamin D insufficiency prevalent among psoriatic arthritis suffers
11. Gifted natural vitamin E tocotrienol protects brain against stroke in 3 ways
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... 2014 Sandata Technologies, LLC, an industry ... care, today announced it released a case study ... Visit Verification™ Solution (EVV™)  for Quality Care Services, ... company founded in 1996 and has five locations ... The study details the challenges facing Quality ...
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
(Date:10/15/2014)... Oct. 15, 2014 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market releases photos and video ... Square on Monday October 13 th . ... Tunnel and angel investor Mr. Chad A. Verdi ... of NXT-ID thanked his investors and employees "for their work and ...
Breaking Biology News(10 mins):Sandata Announces Case Study with Quality Care Services, Inc. 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
... . . Families of thousands of victims ... receive appropriate punishment, because of a suite of technologies ... some graves, perhaps hundreds of thousands remain undiscovered. Researchers ... Oak Ridge National Laboratory are developing a method to ...
... organs in the body has shown to provide effective treatment ... Bristol researchers and published in Nature Communications , could ... carotid body a small nodule (no larger than a ... appears to be a major culprit in the development ...
... with a complex heart condition called hypertrophic cardiomyopathy (HCM) found ... for heart transplantation was greatest for those who developed this ... who also had selective inborn errors of metabolism, a group ... the body,s key metabolic processes are disrupted. The ...
Cached Biology News:September 2013 story tips 2September 2013 story tips 3Size really does not matter when it comes to high blood pressure 2Risk factors help predict outcomes for children with rare heart condition 2
(Date:10/20/2014)... 20, 2014 The report “Pharmacy ... Systems, Packaging and Labeling Systems, Table-top Counters) by ... Global Forecasts & Trends to 2019” analyzes and ... in North America, Europe, Asia-Pacific, and the Rest ... tables and 30 figures spread through 300 pages ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias Biotherapeutics, ... Company has signed a Notice of Grant Award ... (CIRM), effective October 1, 2014.  The NGA provides ... and the release of additional grant funds pursuant ... award for clinical development of Asterias, product, AST-OPC1. ...
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Partners LLC, announced today that Ellen Teplitzky, an ... support for the pharmaceutical industry, has joined the ... of its legal services practice. NDA Partners ... expert witness and testimony, to top law firms ...
Breaking Biology Technology:Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2NDA Partners Appoints Ellen Teplitzky, JD as Director of its Legal Services Practice 2
... and Automation as well as Immunoassay ... and Infectious ... Medical Solutions,Diagnostics, (http://www.siemens.com/diagnostics ), announced today that it ... ), a,Group Purchasing Organization (GPO) and supply chain management ...
... 4 /PRNewswire-FirstCall/ - Ms. Mary Ann Dillahunty, Vice,President, Intellectual ... present a corporate overview of the Company at BIO,InvestorForum ... The conference,will be held at the Palace Hotel in ... audio link to the webcast presentation is available on ...
... CALGARY, Oct. 4 /PRNewswire-FirstCall/ - Resverlogix Corp.,("Resverlogix") (TSX:RVX) ... is,making an oral presentation of key scientific data ... International Symposium for Drugs Affecting,Lipid Metabolism (DALM). The ... A-l and HDL cholesterol", will be presented by,Dr. ...
Cached Biology Technology:MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions 2MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions 3Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007 2Resverlogix Presents Key Apo-Al/HDL Scientific Data at DALM 2